Amyotrophic Lateral Sclerosis Market to Surge Immensely by 2032, Predicts DelveInsight | Key Companies to Watch Out - Cytokinetics, Orphazyme, Orion, Biogen, AB Science, Ionis, Biohaven, MediciNova, NeuroSense
July 19, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, July 19, 2023 (GLOBE NEWSWIRE) -- Amyotrophic Lateral Sclerosis Market to Surge Immensely by 2032, Predicts DelveInsight | Key Companies to Watch Out - Cytokinetics, Orphazyme, Orion,...
Rare Neuromuscular Diseases(NMD) Emerging Pipeline Therapeutics Analysis Report 2022 with Focus on ALS, MG, DMD, SMA, DN & CIDP
December 07, 2022 06:48 ET
|
Research and Markets
Dublin, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The "Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis" report has been added to ResearchAndMarkets.com's offering. Biologics...
Worldwide Amyotrophic Lateral Sclerosis (ALS) Treatment Industry to 2027 - Featuring AB Science, Biogen and Corestream Among Others
December 10, 2021 06:23 ET
|
Research and Markets
Dublin, Dec. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2020-2027 by Treatment Type, ALS Type, Distribution Channel, and Region: Trend Outlook and...
Amyotrophic Lateral Sclerosis Pipeline: Current Treatments, Drug Pipeline and Clinical Trial Outlook | Insights by DelveInsight
June 15, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, June 15, 2021 (GLOBE NEWSWIRE) -- Amyotrophic Lateral Sclerosis Pipeline: Current Treatments, Drug Pipeline and Clinical Trial Outlook | Insights by DelveInsight The pipeline of...
Recent Analysis on Amyotrophic Lateral Sclerosis Clinical Trials
February 22, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Recent Analysis on Amyotrophic Lateral Sclerosis Clinical Trials DelveInsight reports a complete review on Current and Emerging Therapies in...